A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
Clinical trial NCT03288740 · COMPLETED
Trial details
- NCT number
- NCT03288740
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2018-07-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.